TLDR: The Ohio Third Frontier Commission has approved more than $1.1 million in grants to six organizations across the state. This funding, provided through the Technology Validation and Start-up Fund (TVSF), aims to accelerate the research and commercialization of cutting-edge medical and scientific technologies, including significant advancements in artificial intelligence.
COLUMBUS, Ohio – The Ohio Third Frontier Commission announced on July 22, 2025, the approval of over $1.1 million in grant funding to bolster medical and scientific technological innovation within the state. Six Ohio-based organizations are set to receive support through the Technology Validation and Start-up Fund (TVSF), a program designed to facilitate the validation and commercialization of early-stage technologies.
The TVSF initiative provides grants to Ohio companies that are licensing institution-owned technologies, with the goal of accelerating their journey to market. This includes crucial activities such as market research and further prototyping, ultimately helping these companies secure additional funding and bring their licensed innovations to the marketplace more rapidly.
Lydia Mihalik, director of the Ohio Department of Development and chair of the Ohio Third Frontier Commission, emphasized the state’s commitment to future-shaping technologies. “Ohio is committed to investing in the technologies that are shaping the world of tomorrow,” Mihalik stated. “Through these projects, we’re supporting Ohioans who are transforming bold ideas into life-changing breakthroughs.”
Among the notable recipients is Airelon LLC, located in Lewis Center (Delaware County), which was awarded $200,000. This funding will be used to commercialize an artificial intelligence system designed to automatically sort emails, PDFs, and other records for small businesses and local government agencies. The project aims to make AI more accessible to smaller organizations across Ohio, with funds allocated for software development, interface design, and pilot setup. The technology is being licensed from the U.S. Navy.
Other significant awards include:
Auxilium Health, Inc. (Cleveland, Cuyahoga County): Received $200,000 to commercialize wound dressing technology aimed at preventing infections in diabetic foot ulcers.
Recall Therapeutics LLC (Beachwood, Cuyahoga County): Awarded $192,956 to commercialize a novel gene therapy for Alzheimer’s disease, with technology licensed from the University of Cincinnati.
Visano Theranostics Inc. (Fairview Park, Cuyahoga County): Granted $170,000 to commercialize a new imaging approach utilizing gas-filled nanobubbles for improved prostate cancer biopsy accuracy by enhancing tumor visibility during ultrasounds.
Also Read:
- Aidoc Raises $150 Million to Advance Clinical AI for Enhanced Medical Diagnosis and Patient Care
- AI Integration Accelerates in Healthcare and Public Sectors, Reshaping Industries
This investment underscores Ohio’s strategic focus on fostering a robust innovation ecosystem, particularly in the high-growth sectors of medical technology and artificial intelligence.
